Quick Change

What had seemed to the CMO like an impossible evolutionary leap turned out to be a manageable step in their development.

AZ’s Sean Bohen to exit after business overhaul; report

a transitional period to support implementation of the new structure and as CMO until a successor is announced”.

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Exodus continues from Gilead. More changes at Gilead as CMO departs.

Long-serving R&D head Bischofberger to leave Gilead

He’ll retain that responsibility after becoming CMO and add in leadership of the firm’s medical affairs operations.

Takeda forms new women's health and cancer company

Recruits former Medivation CMO Lynn Seely to lead Myovant Sciences. Takeda has siphoned its women's health and prostate cancer operations into a new biopharma firm, created in conjunction with pharmaceutical

25 Women Leaders in UK Healthcare (part 2)

Between 2017 and March 2019 Soraya served as CEO and CMO of Gyroscope and led the company successfully to clinical stage.

Public affairs

Healthcare systems

Medical education

Deal Watch - May 2017

strengthen Kabi’s already strong position in injectables”.  This sounds more like the words of a CMO rather than a developer of biosimilars, which is proving to be a highly competitive

F-star hires ex-BMS immuno-oncology leader

New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Latest movers in pharma and biotech

Industry appointments

Vivaldi heads up Sigilon, Pfizer Oncology loses its CMO and Zelluna appoints new CSO. ... Pfizer Oncology loses its CMO to Allergan. Allergan has poached Pfizer Oncology’s chief medical officer Charles Hugh-Jones (pictured above) to serve as its senior

Redx Pharma appoints new chief medical officer

Dr Andrew Saunders joins the UK biotech from Lytix Biopharma. Drug discovery and development group Redx Pharma has appointed Dr Andrew Saunders as its chief medical officer (CMO), a role that ... He joins the UK biotech from Lytix Biopharma, a Norweigan

Swiss biotech Inositec appoints new chief medical officer

He said: “As CMO of Inositec, I have the golden opportunity to utilise my broad experience and entrepreneurial mind-set to develop new medicines.

Successful brands tell stories

Mastercard CMO Raja Rajamannar explains: “The moment it was launched, there was an immediate connection with customers and there was no looking back and it still resonates — after 17 years —extraordinarily

ONYX Scientific

We are a contract manufacturing pharma organisation (CMO) &chemistry contract research organisation (chemistry CRO)  that provides pharmaceutical chemistry services to large and emerging pharm &biotech companies across the globe, helping